In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Canadian journal of veterinary research = Revue canadienne de recherche veterinaire

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25355997PMCID PMC4170767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Morbillivirus V Proteins Exhibit Multiple Mechanisms to Block Type 1 and Type 2 Interferon Signalling Pathways

  2013influential reference
• The nucleocapsid protein of measles virus blocks host interferon response.

  2012cited by this paper
• In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

  2011cited by this paper
• Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.

  2010cited by this paper
• Pathogenesis and immunopathology of systemic and nervous canine distemper.

  2009cited by this paper
• Identification of a genetic variant of canine distemper virus from clinical cases in two vaccinated dogs in Mexico.

  2008cited by this paper
• Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

  2008cited by this paper
• In vitro efficacy of ribavirin against canine distemper virus.

  2008cited by this paper
• Disease manifestations of canine distemper virus infection in ferrets are modulated by vitamin A status.

  2007cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• In Vitro Evaluation of Antiviral Activity of Ribavirin Against Canine Distemper Virus

  2006cited by this paper
• [Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin].

  2006cited by this paper
• Panencefalitis esclerosante subaguda: tratamiento combinado con interferón alfa y ribavirina intraventricular

  2006cited by this paper
• Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus

  2005cited by this paper
• The interferon response circuit: Induction and suppression by pathogenic viruses

  2005cited by this paper
• Demyelination in canine distemper virus infection: a review

  2005cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• Metabolism and antiviral activity of ribavirin.

  2005cited by this paper
• The Broad Spectrum Antiviral Nucleoside Ribavirin as a Substrate for a Viral RNA Capping Enzyme*

  2004influential reference
• Pharmacokinetics and Effects of Ribavirin following Intraventricular Administration for Treatment of Subacute Sclerosing Panencephalitis

  2004cited by this paper
• Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

  2004cited by this paper
• Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex

  2003cited by this paper
• Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.

  2003cited by this paper
• Synergy, antagonism, and what the chequerboard puts between them.

  2003cited by this paper
• Interferon-alpha as an immunotherapeutic protein.

  2002cited by this paper
• Interferon‐α as an immunotherapeutic protein

  2002cited by this paper
• Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L.

  1999cited by this paper
• Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection

  1997cited by this paper
• Ethanol induces 2',5'-oligoadenylate synthetase and antiviral activities through interferon-beta production.

  1992cited by this paper
• Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses

  1992cited by this paper
• Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

  1991cited by this paper
• Molecular mechanisms of action of ribavirin.

  1990cited by this paper
• Ribavirin response in measles pneumonia.

  1990influential reference
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper

• Automated highly multiplex detection system for respiratory pathogens in canines

  2026cites this paper
• Immunostimulatory effects of multiple short-hairpin RNAs enhance foot-and-mouth disease vaccine-induced humoral immunity.

  2025cites this paper
• Lung and lymph node explants to study the interaction between host cells and canine distemper virus.

  2022cites this paper
• Evaluation of the Efficacy and Safety of Silver Nanoparticles in the Treatment of Non-Neurological and Neurological Distemper in Dogs: A Randomized Clinical Trial

  2022cites this paper
• Phenotypic and Transcriptional Changes of Pulmonary Immune Responses in Dogs Following Canine Distemper Virus Infection

  2022cites this paper
• Donkey-derived anti-CDV IgG, as a passive immunotherapy agent, can effectively increase survival rates of the experimental CDV-infected dogs

  2021cites this paper
• MERS-CoV and Its Impact in the Middle East/Arab World

  2021cites this paper
• Rescuing eGFP-Tagged Canine Distemper Virus for 40 Serial Passages Separately in Ribavirin- and Non-Treated Cells: Comparative Analysis of Viral Mutation Profiles

  2021cites this paper
• Interferon therapies in small animals.

  2021cites this paper
• The effect of interferon alpha administration on cytokine levels in sheep

  2020cites this paper
• Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.

  2020cites this paper
• Identification of a murine cell line that distinguishes virulent from attenuated isolates of the morbillivirus Peste des Petits Ruminants, a promising tool for virulence studies.

  2020cites this paper
• Recovery of NanoLuc Luciferase-Tagged Canine Distemper Virus for Facilitating Rapid Screening of Antivirals in vitro

  2020cites this paper
• Construction of a mavs-inactivated MDCK cell line for facilitating the propagation of canine distemper virus (CDV).

  2019cites this paper
• Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro.

  2017cites this paper
• Type I interferons in the pathogenesis and treatment of canine diseases.

  2017cites this paper
• 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro

  2017cites this paper
• Analyse génomique de la coinfection par le virus VIH et VHC

  2016cites this paper